• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ElevateBio

ElevateBio

Cell and Gene Therapy Innovation Right From The Start

  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Events & Presentations
    • Elevated Insights
  • Careers
  • Contact
  • Search
  • End-to-End Capabilities
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Enabling Services
  • Technology Platforms
    • Technology Platforms Overview
    • Gene Editing
    • Induced Pluripotent Stem Cells (iPSCS)
    • RNA, Cell, Protein & Vector Engineering
  • Therapeutic Design & Approaches
    • Therapeutic Design & Approaches Overview
    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Publications
    • Elevated Insights
  • Careers
  • Contact
  • End-to-End Capabilities


    End-to-End Capabilities Overview

    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Enabling Services
  • Technology Platforms


    Technology Platform Overview

    • Gene Editing
    • Induced Pluripotent Stem Cells (iPSCS)
    • RNA, Cell, Protein & Vector Engineering
  • Therapeutic Design & Approaches


    Therapeutic Design & Approaches Overview

    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers
Home / Team Members / Vikas Sinha

Vikas Sinha

Chief Financial Officer

Follow On LinkedIn

About Vikas

Vikas Sinha brings more than 25 years of experience in executive finance roles in the life sciences industry. He is CFO and co-founder of ElevateBio and also serves as President and CFO of AlloVir, an ElevateBio portfolio company.

Prior to ElevateBio, Vikas served as CFO of Alexion Pharmaceuticals for 11 years, where he was responsible for finance, business development, strategy and IT. During his tenure as CFO, Alexion’s market cap grew from $600 million to more than $30 billion and revenue grew from zero to more than $3 billion.
‍
Prior to joining Alexion, Vikas held various positions with Bayer AG in the United States, Japan, Germany, and Canada, including Vice President and CFO of Bayer Pharmaceuticals Corporation, USA, Vice President and Chief Financial Officer of Bayer Yakuhin Ltd., in Japan. He serves as an independent board member and Audit Committee chair of Verona Pharma Inc.

Education and Accomplishments

Vikas received his M.B.A. from the Asian Institute of Management, Manila, Philippines. He is a qualified Chartered Accountant and associate member of the Institute of Chartered Accountants of India and a Certified Public Accountant in the United States.

Back to team

Footer

ElevateBio

Investors & Media

LinkedIn Twitter

© 2023 ElevateBio. All Rights Reserved.

Privacy & Cookie Policy

  • End-to-End Capabilities
  • Technology Platforms
  • Therapeutic Design & Approaches
  • Partnering
  • About
  • Investors & Media
  • Careers
  • Contact